Considering our new finding that KRAS down-regulated SIRT3 through the guanine exchange factor RCC1 in vitro (Fig. 3), we thus further evaluated the role of RCC1 in affecting pancreatic cancer cell proliferation and tumor growth in vivo. Here, KRAS is linked to pancreatic neoplasm.